New drugs of abuse

Emergency Medicine Clinics of North America

Volumn 18, Issue 4, 2000, Pages 625-636

  Graeme, Kimberlie A ^a,b,c  

^a MARICOPA MEDICAL CENTER   (United States)

^b BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^c Samaritan Regional Poison Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; KETAMINE; PRODRUG;

CARDIOVASCULAR DISEASE; DRUG ABUSE; DRUG COST; DRUG MECHANISM; DRUG METABOLISM; DRUG SYNTHESIS; DRUG URINE LEVEL; INTERNET; METABOLIC DISORDER; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0033659132     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(05)70150-4     Document Type: Article

References (50)

1. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: Utility of diazepam administration
2. Rapid screening test for gamma-hydroxybutyric acid (GHB, fantasy) in urine
3. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: Selective effects on serotonergic systems
4. Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy
5. Designer drugs: A problem in clinical toxicology
6. Gammahydroxybutyrate: An overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent
7. Adverse events associated with ingestion of gamma-butyrolactone - Minnesota, New Mexico, and Texas, 1998-1999
8. Drug-induced hyperthermia
9. gamma-Hydroxybutyrate intoxication and overdose
10. MDMA-induced hyperthermia: Report of a fatality and review of current therapy
11. Ecstasy intoxication: An overlap between serotonin syndrome and neuroleptic malignant syndrome
12. The psychological and physiological effects of MDMA on normal volunteers
13. 1,4-Butanediol, 'pine needle oil': Overdose mimics toxic profile of GHB
14. Gamma-hydroxybutyrate is not a GABA agonist
15. Dystonic reaction after ketamine abuse
16. 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism
17. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy')
18. Subjective reports of the effects of MDMA in a clinical setting
19. Hyponatremia and seizures after ecstasy use
20. Recreational drugs
21. Nonmedical use of ketamine
22. Ketamine: Teaching an old drug new tricks
23. Designer drugs and hallucinogens
24. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
25. A tale of novel intoxication: A review of the effects of gamma-hydroxybutyric acid with recommendations for management
26. A fatal ketamine poisoning
27. Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a 'dietary supplement'
28. The gamma-hydroxybutyrate signaling system in brain: Organization and functional implications
29. Gammahydroxybutyrate: An endogenous regulator of energy metabolism
30. Exaggerated psychomotor response to intravenous bolus dose admimstration of ketamine
31. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
32. Positron emission tomographic evidence of toxic effect of MDMA ('ecstasy') on brain serotonin neurons in human beings
33. Determination of drugs of abuse in blood
34. Tissue distribution of ketamine in a mixed drug fatality
35. Structure-activity relationships of MDMA-like substances
36. Ketamine analgesia, NMDA receptors and the gates of perception
37. Ecstasy: Towards an understanding of the biochemical basis of the actions of MDMA
38. Ketamine: An update on the first twenty-five years of clinical experience
39. Neurotoxic amphetamine analogues: Effects in monkeys and implications for humans
40. MDMA (ecstasy) and the rave: A review
41. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: Possible mechanisms of cell destruction
42. 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy'): Pharmacology and toxicology in animals and humans
43. Significance of gamma-hydroxybutyric acid in the brain
44. Sites of action of gamma-hydroxybutyrate (GHB) - A neuroactive drug with abuse potential
45. Ketamine abusers presenting to the emergency department: A case series
46. The effects of methylenedioxymethamphetamine (MDMA, ecstasy) on monoaminergic neurotransmission in the central nervous system
47. Psychotropic drugs used in anesthesia practice abuse liability and epidemiology of abuse